Publications

Raman micro-spectroscopy for accurate identification of primary human bronchial epithelial cells.

Authors: JM Surmacki, BJ Woodhams, A Haslehurst, BAJ Ponder, SE Bohndiek

E-pub date: 22 Aug 2018

Journal name: Sci Rep

KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.

Authors: ES Polson, VB Kuchler, C Abbosh, EM Ross, RK Mathew, HA Beard, B da Silva, ...

E-pub date: 15 Aug 2018

Journal name: Sci Transl Med

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Authors: JJ Caumanns, K Berns, GBA Wisman, RSN Fehrmann, T Tomar, H Klip, GJ Meersma...

E-pub date: 15 Aug 2018

Journal name: Clin Cancer Res

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

Authors: M Abubakar, J Chang-Claude, HR Ali, N Chatterjee, P Coulson, F Daley, F Blo...

E-pub date: 15 Aug 2018

Journal name: Int J Cancer

A novel Atg5-shRNA mouse model enables temporal control of Autophagy in vivo.

Authors: LD Cassidy, AR Young, PA Pérez-Mancera, B Nimmervoll, A Jaulim, H-C Chen, ...

E-pub date: 1 Aug 2018

Journal name: Autophagy

Correlating MRI radiomics with biology during therapy in cancer models: a tool for drug development?

Authors: H Woodruff, FX Ble, A Jochens, RTH Leijenaar, A Ibrahim, KM Brindle, K Hein...

E-pub date: 1 Aug 2018

Journal name: RADIOTHERAPY AND ONCOLOGY

Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors

Authors: I Rye, A Trinh, A Sætersdal, D Nebdal, OC Lingjærde, V Almendro, K Polyak...

E-pub date: 1 Aug 2018

Journal name:

Network analysis of ChIP-seq data by VULCAN identifies GRHL2 as a key co-regulator of ERa in luminal breast cancer

Authors: A Holding, F Giorgi, A Donnelly, A Cullen, S Nagarajan, L Selth, F Markowet...

E-pub date: 1 Aug 2018

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Raman micro-spectroscopy for accurate identification of primary human bronchial epithelial cells.

KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

A novel Atg5-shRNA mouse model enables temporal control of Autophagy in vivo.

Correlating MRI radiomics with biology during therapy in cancer models: a tool for drug development?

Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors

Network analysis of ChIP-seq data by VULCAN identifies GRHL2 as a key co-regulator of ERa in luminal breast cancer

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Raman micro-spectroscopy for accurate identification of primary human bronchial epithelial cells.

KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

A novel Atg5-shRNA mouse model enables temporal control of Autophagy in vivo.

Correlating MRI radiomics with biology during therapy in cancer models: a tool for drug development?

Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors

Network analysis of ChIP-seq data by VULCAN identifies GRHL2 as a key co-regulator of ERa in luminal breast cancer